← All indications
Wet Macular Degeneration
A form of RETINAL DEGENERATION in which abnormal CHOROIDAL NEOVASCULARIZATION occurs under the RETINA and MACULA LUTEA, causing bleeding and leaking of fluid. This leads to bulging and or lifting of the macula and the distortion or destruction of central vision.
Drugs by status
Approved for this indication (6)
Phase 4 trials (2)
Phase 3 trials (17)
Phase 2 trials (19)
Phase 1 trials (14)
Organizations
Organization Involved with Phase 4 Indications (28)
- Regeneron
- Novartis
- Bayer
- Barcelona Macula Foundation
- Huazhong University of Science and Technology
- Central South University
- Hospital Son Espases
- Institut de la Macula y la Retina
- Nagoya City University
- Osaka University
- Retinal Consultants of Arizona
- Seoul National University
- Universidad Complutense de Madrid
- Vista Klinik
- Wake Forest University
- Fudan University
- University of California, Los Angeles
- University of California, San Diego
- Jiao Tong University
- Hebrew University
- Hospital Universitari General de Catalunya
- Hospital Universitario de Albacete
- Institut Catala de Retina
- University of Barcelona
- University of Brescia
- Johannes Gutenburg University
- TFS Trial Form Support
- University of Las Palmas de Gran Canaria
Organization Involved with Phase 3 Indications (16)
- Roche
- Lupin
- Alcon
- Chengdu Kanghong Biotech Co.,Ltd.
- Mid-Atlantic Retina Consultations, Inc.
- Centre Hospitalier Intercommunal Creteil
- University of London
- Kyung Hee University
- St. Erik Eye Hospital
- Thomas Jefferson University
- Pacific Eye Associates
- University of California, San Francisco
- BioEq
- Samsung
- Outlook Pharmaceuticals
- Sam Chun Dang Pharm. Co. Ltd.
Organization Involved with Phase 2 Indications (38)
- Aerie Pharmaceuticals
- Clearside Biomedical, Inc.
- Hamilton Health Sciences Corporation
- Iconic Therapeutics, Inc.
- Opthea Pty Ltd.
- PanOptica, Inc.
- Regenxbio Inc.
- Southeast Clinical Research Associates, LLC
- Tyrogenex
- Apellis Pharmaceuticals, Inc.
- Boehringer Ingelheim
- Vastra Gotaland Region
- Bascom Palmer Eye Institute
- Bay Area Retina Associates
- McMaster University
- Sichuan University
- University of Iowa
- University of Miami
- University of Oslo
- University of Padova
- University of Toronto
- Vitreous -Retina- Macula Consultants of New York (VRMNY)
- Peking University
- Bar Ilan University
- University of Wisconsin
- University of Western Ontario
- J. Arch McNamara Research Fund
- Beijing DMS Pharma Ltd.
- The Digital Angiography Reading Center (DARC)
- Conegliano Hospital, Treviso
- +8 more
Organization Involved with Phase 1 Indications (11)
Organization Involved with Other Experimental Indications (10)